1 Market Overview of HIV Integrase Strand Transfer Inhibitors (INSTI) 1.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Overview 1.1.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Scope 1.1.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Status and Outlook 1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2016-2027) 1.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Region (2016-2021) 1.5 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Region (2022-2027) 1.6 Key Regions, HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 1.6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 1.6.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 1.6.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 1.6.4 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 1.6.5 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Overview by Type 2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Type (2016-2021) 2.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2022-2027) 2.4 Raltegravir 2.5 Elvitegravir Combination Drugs 2.6 Dolutegravir and Its Combination Drug 2.7 Bictegravir Combination Drug 2.8 Cabotegravir 2.9 Other 3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Overview by Application 3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Application (2016-2021) 3.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2022-2027) 3.4 Hospital 3.5 Clinic 3.6 Drug Center 3.7 Other 4 HIV Integrase Strand Transfer Inhibitors (INSTI) Competition Analysis by Players 4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2020) 4.3 Date of Key Players Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market 4.4 Global Top Players HIV Integrase Strand Transfer Inhibitors (INSTI) Headquarters and Area Served 4.5 Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service 4.6 Competitive Status 4.6.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Adcock Ingram Limited 5.1.1 Adcock Ingram Limited Profile 5.1.2 Adcock Ingram Limited Main Business 5.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.1.4 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.1.5 Adcock Ingram Limited Recent Developments 5.2 Affine Formulations Limited 5.2.1 Affine Formulations Limited Profile 5.2.2 Affine Formulations Limited Main Business 5.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.2.4 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.2.5 Affine Formulations Limited Recent Developments 5.3 Aurobindo Pharma 5.5.1 Aurobindo Pharma Profile 5.3.2 Aurobindo Pharma Main Business 5.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.3.4 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.3.5 Biocon Limited Recent Developments 5.4 Biocon Limited 5.4.1 Biocon Limited Profile 5.4.2 Biocon Limited Main Business 5.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.4.4 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.4.5 Biocon Limited Recent Developments 5.5 Bristol-Myers Squibb 5.5.1 Bristol-Myers Squibb Profile 5.5.2 Bristol-Myers Squibb Main Business 5.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.5.4 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.5.5 Bristol-Myers Squibb Recent Developments 5.6 Cipla 5.6.1 Cipla Profile 5.6.2 Cipla Main Business 5.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.6.4 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.6.5 Cipla Recent Developments 5.7 Emcure Pharmaceuticals 5.7.1 Emcure Pharmaceuticals Profile 5.7.2 Emcure Pharmaceuticals Main Business 5.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.7.4 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.7.5 Emcure Pharmaceuticals Recent Developments 5.8 Flamingo Pharmaceuticals Limited 5.8.1 Flamingo Pharmaceuticals Limited Profile 5.8.2 Flamingo Pharmaceuticals Limited Main Business 5.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.8.4 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.8.5 Flamingo Pharmaceuticals Limited Recent Developments 5.9 Gilead Sciences 5.9.1 Gilead Sciences Profile 5.9.2 Gilead Sciences Main Business 5.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.9.4 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.9.5 Gilead Sciences Recent Developments 5.10 Hetero Drugs 5.10.1 Hetero Drugs Profile 5.10.2 Hetero Drugs Main Business 5.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.10.4 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.10.5 Hetero Drugs Recent Developments 5.11 IPCA Laboratories 5.11.1 IPCA Laboratories Profile 5.11.2 IPCA Laboratories Main Business 5.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.11.4 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.11.5 IPCA Laboratories Recent Developments 5.12 Janssen Pharmaceutica (Johnson & Johnson) 5.12.1 Janssen Pharmaceutica (Johnson & Johnson) Profile 5.12.2 Janssen Pharmaceutica (Johnson & Johnson) Main Business 5.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.12.4 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.12.5 Janssen Pharmaceutica (Johnson & Johnson) Recent Developments 5.13 LAURUS Labs 5.13.1 LAURUS Labs Profile 5.13.2 LAURUS Labs Main Business 5.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.13.4 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.13.5 LAURUS Labs Recent Developments 5.14 Medisist Pharma 5.14.1 Medisist Pharma Profile 5.14.2 Medisist Pharma Main Business 5.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.14.4 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.14.5 Medisist Pharma Recent Developments 5.15 Merck 5.15.1 Merck Profile 5.15.2 Merck Main Business 5.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.15.4 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.15.5 Merck Recent Developments 5.16 Mylan 5.16.1 Mylan Profile 5.16.2 Mylan Main Business 5.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.16.4 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.16.5 Mylan Recent Developments 5.17 Ranbaxy Pharmaceuticals 5.17.1 Ranbaxy Pharmaceuticals Profile 5.17.2 Ranbaxy Pharmaceuticals Main Business 5.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.17.4 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.17.5 Ranbaxy Pharmaceuticals Recent Developments 5.18 Shanghai Desano Pharmaceuticals 5.18.1 Shanghai Desano Pharmaceuticals Profile 5.18.2 Shanghai Desano Pharmaceuticals Main Business 5.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.18.4 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.18.5 Shanghai Desano Pharmaceuticals Recent Developments 5.19 ViiV Healthcare (GSK) 5.19.1 ViiV Healthcare (GSK) Profile 5.19.2 ViiV Healthcare (GSK) Main Business 5.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions 5.19.4 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) & (2016-2021) 5.19.5 ViiV Healthcare (GSK) Recent Developments 6 North America 6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Dynamics 11.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Trends 11.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers 11.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges 11.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2016-2021) & (US$ Million) Table 3. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Region (2016-2021) Table 4. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size Share by Region (2022-2027) Table 6. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) & (US$ Million) Table 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2016-2021) Table 9. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2022-2027) Table 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) & (US$ Million) Table 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2016-2021) Table 14. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2022-2027) Table 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (US$ Million) by Players (2016-2021) Table 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2020) Table 19. Date of Key Manufacturers Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market Table 20. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Top Players Headquarters and Area Served Table 21. HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service Table 22. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Adcock Ingram Limited Basic Information List Table 25. Adcock Ingram Limited Description and Business Overview Table 26. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 27. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Adcock Ingram Limited (2016-2021) Table 28. Adcock Ingram Limited Recent Developments Table 29. Affine Formulations Limited Basic Information List Table 30. Affine Formulations Limited Description and Business Overview Table 31. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 32. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Affine Formulations Limited (2016-2021) Table 33. Affine Formulations Limited Recent Developments Table 34. Aurobindo Pharma Basic Information List Table 35. Aurobindo Pharma Description and Business Overview Table 36. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 37. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Aurobindo Pharma (2016-2021) Table 38. Aurobindo Pharma Recent Developments Table 39. Biocon Limited Basic Information List Table 40. Biocon Limited Description and Business Overview Table 41. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 42. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Biocon Limited (2016-2021) Table 43. Biocon Limited Recent Developments Table 44. Bristol-Myers Squibb Basic Information List Table 45. Bristol-Myers Squibb Description and Business Overview Table 46. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 47. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Bristol-Myers Squibb (2016-2021) Table 48. Bristol-Myers Squibb Recent Developments Table 49. Cipla Basic Information List Table 50. Cipla Description and Business Overview Table 51. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 52. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Cipla (2016-2021) Table 53. Cipla Recent Developments Table 54. Emcure Pharmaceuticals Basic Information List Table 55. Emcure Pharmaceuticals Description and Business Overview Table 56. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 57. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Emcure Pharmaceuticals (2016-2021) Table 58. Emcure Pharmaceuticals Recent Developments Table 59. Flamingo Pharmaceuticals Limited Basic Information List Table 60. Flamingo Pharmaceuticals Limited Description and Business Overview Table 61. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 62. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Flamingo Pharmaceuticals Limited (2016-2021) Table 63. Flamingo Pharmaceuticals Limited Recent Developments Table 64. Gilead Sciences Basic Information List Table 65. Gilead Sciences Description and Business Overview Table 66. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 67. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Gilead Sciences (2016-2021) Table 68. Gilead Sciences Recent Developments Table 69. Hetero Drugs Basic Information List Table 70. Hetero Drugs Description and Business Overview Table 71. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 72. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Hetero Drugs (2016-2021) Table 73. Hetero Drugs Recent Developments Table 74. IPCA Laboratories Basic Information List Table 75. IPCA Laboratories Description and Business Overview Table 76. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 77. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of IPCA Laboratories (2016-2021) Table 78. IPCA Laboratories Recent Developments Table 79. Janssen Pharmaceutica (Johnson & Johnson) Basic Information List Table 80. Janssen Pharmaceutica (Johnson & Johnson) Description and Business Overview Table 81. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 82. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Janssen Pharmaceutica (Johnson & Johnson) (2016-2021) Table 83. Janssen Pharmaceutica (Johnson & Johnson) Recent Developments Table 84. LAURUS Labs Basic Information List Table 85. LAURUS Labs Description and Business Overview Table 86. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 87. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of LAURUS Labs (2016-2021) Table 88. LAURUS Labs Recent Developments Table 89. Medisist Pharma Basic Information List Table 90. Medisist Pharma Description and Business Overview Table 91. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 92. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Medisist Pharma (2016-2021) Table 93. Medisist Pharma Recent Developments Table 94. Merck Basic Information List Table 95. Merck Description and Business Overview Table 96. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 97. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Merck (2016-2021) Table 98. Merck Recent Developments Table 99. Mylan Basic Information List Table 100. Mylan Description and Business Overview Table 101. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 102. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Mylan (2016-2021) Table 103. Mylan Recent Developments Table 104. Ranbaxy Pharmaceuticals Basic Information List Table 105. Ranbaxy Pharmaceuticals Description and Business Overview Table 106. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 107. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Ranbaxy Pharmaceuticals (2016-2021) Table 108. Ranbaxy Pharmaceuticals Recent Developments Table 109. Shanghai Desano Pharmaceuticals Basic Information List Table 110. Shanghai Desano Pharmaceuticals Description and Business Overview Table 111. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 112. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of Shanghai Desano Pharmaceuticals (2016-2021) Table 113. Shanghai Desano Pharmaceuticals Recent Developments Table 114. ViiV Healthcare (GSK) Basic Information List Table 115. ViiV Healthcare (GSK) Description and Business Overview Table 116. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Products, Services and Solutions Table 117. Revenue (US$ Million) in HIV Integrase Strand Transfer Inhibitors (INSTI) Business of ViiV Healthcare (GSK) (2016-2021) Table 118. ViiV Healthcare (GSK) Recent Developments Table 119. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million) Table 120. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million) Table 121. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million) Table 122. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million) Table 123. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2016-2021) & (US$ Million) Table 124. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2022-2027) & (US$ Million) Table 125. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2016-2021) Table 126. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2022-2027) Table 127. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million) Table 128. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million) Table 129. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Players (2016-2021) & (US$ Million) Table 130. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million) Table 131. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Trends Table 132. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers Table 133. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges Table 134. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions: 2021 VS 2027 Figure 4. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size Share by Region (2022-2027) Figure 5. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Type in 2021 & 2027 Figure 11. Raltegravir Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Elvitegravir Combination Drugs Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Dolutegravir and Its Combination Drug Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Bictegravir Combination Drug Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Cabotegravir Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Application in 2021 & 2027 Figure 18. Hospital Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Clinic Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Drug Center Market Size (US$ Million) YoY Growth (2016-2027) Figure 21. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 22. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Top 5 and Top 10 Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share in 2020 Figure 24. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027) Figure 25. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 26. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 27. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 28. France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 29. U.K. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 30. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 31. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 32. Nordic HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 33. Rest of Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 34. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2016-2027) Figure 35. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 36. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 37. South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 38. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 39. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 40. Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 42. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027) Figure 43. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 44. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 45. Rest of Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 46. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027) Figure 47. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 48. Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 49. UAE HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 50. Rest of Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) & (US$ Million) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation

Adcock Ingram Limited Affine Formulations Limited Aurobindo Pharma Biocon Limited Bristol-Myers Squibb Cipla Emcure Pharmaceuticals Flamingo Pharmaceuticals Limited Gilead Sciences Hetero Drugs IPCA Laboratories Janssen Pharmaceutica (Johnson & Johnson) LAURUS Labs Medisist Pharma Merck Mylan Ranbaxy Pharmaceuticals Shanghai Desano Pharmaceuticals ViiV Healthcare (GSK)